Variantyx News & Events

News: Exomes are a Transition Test

Frontline Genomics

December 6, 2017 | Front Line Genomics recently interviewed Variantyx CEO Haim Neerman at the American Society of Human Genetics conference in Orlando, Florida, where they discussed why whole genome sequencing is the future of genomic diagnostic testing …

Read More ...
Scroll Up